23 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
related to drug pricing and payments and other transfers of value to physicians and other healthcare providers and restrict marketing practices … President Biden that includes a proposed prescription drug pricing model that will test whether targeted Medicare payment adjustments
ARS
t2pq2koebz8ne79e
28 Apr 23
Annual report to shareholders
7:03am
424B4
bsvje7bmmhyf02ku0n
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
tv3ecir 3l
19 May 21
Draft registration statement
12:00am
10-K
it8mf7 so26300r6ho7
11 Mar 21
Annual report
4:19pm
10-Q
y4qtr1dkb9f1qxjffc
12 Nov 20
Quarterly report
4:28pm
424B4
2p72vnsnxrx90c3m
2 Oct 20
Prospectus supplement with pricing info
5:10pm